Moderna stock price soars 160% on melanoma vaccine success

· businessinsider.com

Moderna has been looking for its next blockbuster drug after a wildly successful COVID era.

After making its name as a vaccine-maker during the COVID era, Moderna has been looking for its second act as a major drug developer. Investors seem to think it...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI